Literature DB >> 23472735

Vascular distribution of glioblastoma multiforme at diagnosis.

K Yohay1, D S Wolf, L J Aronson, M Duus, E R Melhem, K J Cohen.   

Abstract

Treatment of high-grade gliomas with selective intra-arterial (IA) administration of chemotherapies has been proposed, and utilized as a therapeutic modality. This approach offers the conceptual benefit of providing maximal delivery of the agent to the tumor bed, while potentially reducing systemic exposure to the agent. This retrospective study was designed to determine the vascular distribution of glioblastoma multiforme (GBM) at the time of diagnosis in an effort to determine what proportion of patients would likely be candidates for this approach. The preoperative MRI scans of 50 patients with GBM were analyzed and compared to published normative data of intracranial vascular distribution. Vascular distribution was determined by analyzing post-gadolinium axial and coronal T1 images, axial T2 images, and axial T2 images with an additional 1 cm margin (T2 + 1 cm) added in all dimensions. T1 analysis demonstrated 60% of tumors in a single vascular distribution. T2 analysis of these tumors reduced that number to 34%. When the T2 + 1 cm margin was utilized, only 6% of tumors were in a single vascular distribution. 66% of tumors were limited to the anterior circulation on T1 imaging but only 34% on T2 + 1 cm imaging. 30% of tumors were also within the distribution of the anterior choroidal artery. These findings suggest that the use of selective IA administration of agents is necessarily limited to a fraction of presenting patients or will require administration via multiple cerebral arteries.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23472735      PMCID: PMC3601610          DOI: 10.1177/159101991301900119

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  20 in total

1.  Variability of the territories of the major cerebral arteries.

Authors:  A van der Zwan; B Hillen; C A Tulleken; M Dujovny; L Dragovic
Journal:  J Neurosurg       Date:  1992-12       Impact factor: 5.115

2.  Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas.

Authors:  Wataru Watanabe; Rika Kuwabara; Toshinori Nakahara; Osamu Hamasaki; Ikuo Sakamoto; Koji Okada; Atsushi Minamoto; Hiromu K Mishima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-11-09       Impact factor: 3.117

3.  Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series.

Authors:  Benjamin J Shin; Jan-Karl Burkhardt; Howard A Riina; John A Boockvar
Journal:  Neurosurg Clin N Am       Date:  2012-02-18       Impact factor: 2.509

4.  Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

Authors:  N D Doolittle; M E Miner; W A Hall; T Siegal; E Jerome; E Osztie; L D McAllister; J S Bubalo; D F Kraemer; D Fortin; R Nixon; L L Muldoon; E A Neuwelt
Journal:  Cancer       Date:  2000-02-01       Impact factor: 6.860

5.  Ocular and orbital complications of intraarterial cisplatin. A case report.

Authors:  H M Wu; A G Lee; D E Lehane; T L Chi; R A Lewis
Journal:  J Neuroophthalmol       Date:  1997-09       Impact factor: 3.042

6.  Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors.

Authors:  A Tfayli; P Hentschel; S Madajewicz; J Manzione; N Chowhan; R Davis; P Roche; A Iliya; C Roque; A Meek; M Shady
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

7.  Pathology of high-dose intraarterial BCNU.

Authors:  B K Kleinschmidt-DeMasters; J M Geier
Journal:  Surg Neurol       Date:  1989-06

8.  Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors.

Authors:  Tatsuya Abe; Hiroaki Wakimoto; Robert Bookstein; Daniel C Maneval; E Antonio Chiocca; James P Basilion
Journal:  Cancer Gene Ther       Date:  2002-03       Impact factor: 5.987

9.  Pathologic anatomy and CT correlations in the glioblastoma multiforme.

Authors:  P C Burger
Journal:  Appl Neurophysiol       Date:  1983

10.  Intraarterial cis-platinum chemotherapy for patients with primary and metastatic brain tumors.

Authors:  D E Lehane; R N Bryan; B Horowitz; L DeSantos; G Ehni; M A Zubler; R Moiel; L Rudolph; A Aldama-Leubbert; D Mahoney
Journal:  Cancer Drug Deliv       Date:  1983
View more
  3 in total

Review 1.  Novel therapeutic delivery approaches in development for pediatric gliomas.

Authors:  Katherine E Warren
Journal:  CNS Oncol       Date:  2013-09

Review 2.  Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma.

Authors:  Katherine Elizabeth Warren
Journal:  Front Oncol       Date:  2018-07-03       Impact factor: 6.244

3.  Uncovering a Distinct Gene Signature in Endothelial Cells Associated With Contrast Enhancement in Glioblastoma.

Authors:  Fan Yang; Yuan Xie; Jiefu Tang; Boxuan Liu; Yuancheng Luo; Qiyuan He; Lingxue Zhang; Lele Xin; Jianhao Wang; Sinan Wang; Shuqiang Zhang; Qingze Cao; Liang Wang; Liqun He; Lei Zhang
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.